Why the study?
The study was conducted to examine the effect of diabetes mellitus and hypertension on renal function in Shendi locality at River Nile State in Northern Sudan.
Do diabetes mellitus and hypertension increase microalbuminuria and albumin/creatinine ratio in Sudanese patients?
Do diabetes mellitus and hypertension increase microalbuminuria and albumin/creatinine ratio in Sudanese patients?
Diabetes and hypertension are associated with significantly higher microalbuminuria and albumin/creatinine ratio, indicating early renal dysfunction.
DM/HTN-associated microalbuminuria signals early renal risk warranting screening; leaves open causality and intervention benefits in this population.
Microalbuminuria in urine is a known indicator of renal dysfunction. It has been extensively studied in the diabetes mellitus and hypertensive patients. This study was cross-sectional, descriptive case-control, hospital based, conducted, in Shendi locality at River Nile State in Northern Sudan, from March to July 2018. It intended to examine the effect of diabetes mellitus and hypertension on renal function. Urine and venous blood samples were collected sixty (60) volunteer subjects, thirty-five (35) of them known as diabetic and hypertensive patients as case group, twenty-five (25) healthy subjects as control group. Samples were examined for urine microalbuminuria and plasma creatinine levels. Case and control groups were compared by age, gender and exercise. Albumin/Creatinine Ratio (ACR). was also assessed. The mean microalbuminuria and mean ACR were significantly higher in case group (38.304mg/dl, (6.8226) mg/mmol) compared to control group (13.020mg/dl, 2.4512) mg/mmol.), with statistically significant P. value (0.007) and (0.000) respectively. There was statistically insignificant variation of the means of plasma creatinine between case and control groups (0.88, 0.948) mg/dl with P. value of (0.285). The present study concluded that diabetes and hypertension were associated with microalbuminuria and renal dysfunction.
No takes yet. Share an insight, caveat, or question.
Khair et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: